Adverse drug events in oncologic patient hospitalized
Keywords:Palavras-chave: Eventos adversos a medicamentos, segurança do paciente, trigger tool, oncologia.
Objective: To identify adverse drug events in cancer patients treated in a large hospital in the expanded region of the Mid-West of Minas Gerais.
Methods: A retrospective, exploratory and descriptive study with a quantitative approach, which took place the application of tracers proposed by the Institute for Healthcare Improvement as a strategy for identifying adverse drug events. Data collection was based on random selection from the medical records of patients of all ages who were diagnosed with cancer and progressed to death in the period July 2014 to June 2015.
Results: From the evaluation of 80 medical records, were detected 126 trackers that were present in 75 (93.7%) of the records relating to hospitalized cancer patients. These trackers led to the identification of 95 events adverse drug in 71 (88.7%) of the records in question.
Conclusion: The observation of a high rate of adverse drug events is a threat and can cause serious damage to the health of cancer patients treated at the hospital under study. In this context, it is essential to adopt strategies to reduce the occurrence of adverse events and intensify activities aimed at patient safety.
How to Cite
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.